facebook

What Is a Laser Eye Surgery Enhancement?

1 min read

A laser eye surgery enhancement, sometimes referred to as a “top-up,” is a secondary refractive procedure performed after the eye has stabilised in order to refine a small residual refractive error.

Modern excimer laser systems are extraordinarily precise. Large international outcome analyses confirm that more than 90–95% of patients achieve results within ±0.50 dioptres of intended target following primary LASIK treatment¹. However, refractive surgery occurs within a living cornea. Healing, epithelial remodelling and biomechanical redistribution introduce biological variability that cannot be entirely eliminated.

Enhancement becomes appropriate when:

  • A small degree of residual myopia, hyperopia or astigmatism remains
  • Regression occurs months or years after treatment
  • Visual quality is high but not optimal
  • Residual ametropia persists after cataract or lens replacement surgery

Retreatment rates following LASIK typically range between 2–10%, depending on starting prescription and length of follow-up². Higher refractive magnitude and younger age are recognised predictors of enhancement likelihood².

Importantly, enhancement is not a complication. It is precision refinement. Multiple systematic reviews confirm that when appropriate screening is performed, including assessment of residual stromal bed thickness and corneal topography, enhancement outcomes remain highly predictable and safe³.

Refractive surgery should be understood as a managed pathway rather than a single event. Enhancement is an expected refinement in a small percentage of patients and reflects long-term outcome optimisation, not treatment failure.

References

  1. Sandoval HP, Donnenfeld ED, Kohnen T, et al. Modern laser in situ keratomileusis outcomes. J Cataract Refract Surg. 2016;42(8):1224-1234.
  2. Randleman JB, White AJ, Lynn MJ, Stulting RD. Incidence, outcomes, and risk factors for retreatment after LASIK. Ophthalmology. 2009;116(11):2100-2107.
  3. Shortt AJ, Allan BD, Evans JR. Laser-assisted in situ keratomileusis (LASIK) for myopia and myopic astigmatism. Cochrane Database Syst Rev. 2013;(1):CD005101.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.